Farmacosmo S.P.A.
MMIL:COSMO0.44
EUR
+0.02
(+4.52%)
ISIN
IT0005487670
Return %
Stock
S&P 500
1Y
-5.18
14.20
3Y
-35.06
81.12
5Y
- -
68.34
Capital Structure
EUR
•
in mil. unless spec.Working Capital
EUR
•
in mil. unless spec.Growth Rates
EUR
•
in mil. unless spec.Semi-annual Revenue
EUR
•
in mil. unless spec.Semi-annual Earnings Per Share
EUR
•
in mil. unless spec.Semi-annual Dividends Per Share
EUR
•
in mil. unless spec.Company Description
- CEO
- Fabio de Concilio
- Full Time Employees
- 87
- Sector
- Retail trade
- Industry
- Specialty stores
- Address
- Naples Italy
- IPO Date
- Mar 30, 2022
- Website
- farmacosmo.com
- Similar Companies
- Business
- Farmacosmo S.p.A. is an Italy-based digital retailer and health-tech company engaged in the online distribution of pharmaceuticals, personal wellness, beauty, and pet care products, alongside the provision of integrated digital healthcare solutions. Founded in 2014 and headquartered in Naples, Italy, the company operates proprietary B2C e-commerce platforms and B2B channels primarily serving the Italian domestic market and expanding into select European territories. Farmacosmo organizes its commercial offerings across specialized business segments, including Health & Pharma, Beauty & Fragrances, Personal Care, Pet Care, Mother & Child, and Digital Health. Its comprehensive product and service portfolio includes over-the-counter (OTC) pharmaceuticals and non-prescription medicines; dietary supplements, vitamins, and nutraceuticals; dermocosmetics, skincare treatments, hair care solutions, fragrances, and luxury makeup; personal hygiene, dental care, and sanitization items; medical devices, diagnostic testing kits, orthopedic supports, and health monitoring equipment; infant nutrition, baby care essentials, and maternity products; veterinary medicines, specialty pet food, and pet hygiene accessories; optical goods, contact lenses, and eye care solutions; and digital telemedicine services, including remote specialist consultations and telecardiology diagnostics. In recent corporate developments, Farmacosmo completed its listing on the Euronext Growth Milan exchange to accelerate external expansion and technological innovation. The company has executed a targeted merger and acquisition campaign, acquiring majority stakes in online perfumery platform ProfumeriaWeb to strengthen its selective beauty and cosmetics vertical, e-pharmacy platform Phàrmasi to consolidate its core online pharmaceutical market share, and Contacta to expand into the optical and vision-care market. Additionally, Farmacosmo acquired Telemedico to integrate remote diagnostic and teleconsultation services into its digital platform, entered the eco-sustainable pet care segment through the acquisition of Bau Cosmesi, and formed strategic alliances with specialized logistics and pharmaceutical partners to enhance automated order fulfillment and rapid delivery operations.